Rapid immunoassay for the determination of glial fibrillary acidic protein (GFAP) in serum
- 30 April 2006
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 366 (1-2) , 336-340
- https://doi.org/10.1016/j.cca.2005.11.017
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Raised Serum S100B Levels after Acute Bone Fractures without Cerebral InjuryPublished by Wolters Kluwer Health ,2005
- Effects of Head and Extracranial Injuries on Serum Protein S100B Levels in Trauma PatientsPublished by Wolters Kluwer Health ,2004
- Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patientsBrain Research Bulletin, 2003
- Increase in serum S100A1-B and S100BB during cardiac surgery arises from extracerebral sourcesThe Annals of Thoracic Surgery, 2001
- Early Neurobehavioral Outcome After Stroke Is Related to Release of Neurobiochemical Markers of Brain DamageStroke, 1999
- S-100 Protein and Neuron-Specific Enolase Concentrations in Blood as Indicators of Infarction Volume and Prognosis in Acute Ischemic StrokeStroke, 1997
- Serum S-100 Protein, Relationship to Clinical Outcome in Acute StrokeAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1997
- Leakage of brain-originated proteins in peripheral blood: temporal profile and diagnostic value in early ischemic strokeJournal of the Neurological Sciences, 1997
- Determination in human cerebrospinal fluid of glial fibrillary acidic protein, S-100 and myelin basic protein as indices of non-specific or specific central nervous tissue pathologyClinica Chimica Acta; International Journal of Clinical Chemistry, 1986
- An acidic protein isolated from fibrous astrocytesBrain Research, 1971